Volume 7, Issue 4, pp. 359-368
- Received November 22, 2016.
- Revision received January 5, 2017.
- Accepted February 28, 2017.
- Published first March 20, 2017.
Copyright & Usage
©2017 American Association for Cancer Research.
View Full Text
- 1Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain.
- 2Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.
- 3Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Catalonia, Spain.
- 4Cancer Research Institute, Beth Israel Deaconess Cancer Center, Departments of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
- ↵*Corresponding Authors:
Pier Paolo Pandolfi, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, CLS Suite 401, Boston, MA 02215. Phone: 617-735-2141; Fax: 617-735-2120; E-mail: ; and Manel Esteller, Cancer Epigenetics and Biology Program, 3rd Floor, Hospital Duran i Reynals, Avda. Gran Via Km 2.7, 08908 L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. Phone: 34-93-2607140; Fax: 34-93-2607219; E-mail: